Related Experiment Video
Updated: Nov 27, 2025
08:23
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
11.5K
Epilepsy and TSC-Associated Neuropsychiatric Disorders
1Department of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Pediatric Neurology Briefs
|December 7, 2020
Summary
This study examined epilepsy and neuropsychiatric conditions in individuals with Tuberous Sclerosis Complex (TSC). Findings explore the link between these conditions and genetic factors in TSC patients.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Tuberous Sclerosis Complex (TSC) is a genetic disorder affecting multiple organs.
- Epilepsy and neuropsychiatric disorders are common in individuals with TSC.
- The influence of genotype on these comorbidities is not fully understood.
Purpose of the Study:
- To investigate the relationship between epilepsy and neuropsychiatric disorders in TSC.
- To explore the potential impact of TSC genotype on the occurrence of these conditions.
Main Methods:
- Utilized the Tuberous Sclerosis Complex Natural History Database (TSCNHD).
- Retrospective analysis of patient data from multiple institutions.
- Correlated clinical data with genotypic information.
Main Results:
- Epilepsy is highly prevalent in the TSC cohort.
- Specific neuropsychiatric disorders show varying associations with epilepsy.
- Preliminary genotype-phenotype correlations suggest potential links.
Conclusions:
- Epilepsy and neuropsychiatric disorders are significant comorbidities in TSC.
- Genotype may play a role in the manifestation of these conditions.
- Further research is warranted to elucidate genotype-phenotype relationships in TSC.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
917
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
917
01:13Seizures: Classification
1.1K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
636
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
636
01:30Electroconvulsive Therapy
434
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
434
01:14Antiepileptic Drugs: Glutamate Antagonists
714
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
714
01:20Antiepileptic Drugs: Potassium Channel Activators
456
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
456